This promotional webinar has been funded and developed by Novartis UK Ltd and is intended for UK healthcare professionals only.
Three key takeaways
- Emphasise the urgency to lower LDL-C to target, defining the secondary prevention LDL-C targets and national guidelines.
- Real-world experiences of implementing lipid lowering therapies within general practice including practical tips for identifying and initiating patients eligible for escalated lipid lowering therapy.
- Share learnings and discuss importance of the role of pharmacy teams in implementing lipid lowering therapies in primary care.
Chair:
Nipa Patel, PCPA Regional Vice President - London and SE| Lead Pharmacist SASSE 2 & 3
Speakers:
Prof Raj Thakkar, PCCS President and CKD representative GP Partner
Sarah Trust, MPharm Clinical Pharmacist, Brighton & Sussex PCN